fda drug safety communication semaglutide naion 2025 The obesity (Wegovy) conferred a significantly higher risk of ischemic optic neuropathy (ION) than any other GLP-1 agonist, including semaglutide for diabetes (Ozempic), an analysis of data showed. Added Rybelsus Lawsuit Update May 2026

Zpomalen projev strnut (Anti-aging) : Pro ochranu pleti a vnitnch orgn ped oxidativnm stresem

Carnitine has a protective effect on glaucoma-induced retinal ganglion cells injury by reducing the expression of typical markers of cell stress, such as glial fibrillary acidic protein (GFAP), inducible nitric oxide synthase (iNOS), ubiquitin and caspase-3, and reducing the level of the lipid peroxidation product malondialdehyde (MDA) [318]

Known Unknowns & Insurance Uncertainty While FDA approval of Wegovy for MASH is a milestone, significant coverage questions remain unresolved: 1

Control uninfected adjacent root tissue was collected from the same plants